TrialPanorama/Dataset huggingface dataset:
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Analysis of the Impact in the Quality of Life of Patients With Pain Secondary to Osteoporotic Vertebral Fractures Receiving Conservative Treatment Versus Percutaneous Vertebroplasty
Brief Summary: The purpose of this study is to determine whether percutaneous vertebroplasty is able to improve long-term quality of life in patients with pain secondary to osteoporotic vertebral fractures, compared to conventional medical treatment.


Options:
A: * \> or = 50 years of age
* Compression fracture (T4-L5)within previous 12 mo.
* Pain from compression fracture
* No malignant tumor
* No back surgery
B: Inclusion Criteria:

* Painful (pain intensity of at least 4 on a scale from 0 to 10) osteoporotic vertebral fracture between levels T4 and L5
* Fragility; i.e. fracture not in relation with significant trauma
* Recent fracture, pain beginning not earlier than 1 year before inclusion

Exclusion Criteria:

* No vertebral edema on STIR MR images
* Uncorrectable bleeding diatheses
* Active infection
* Substantial retropulsion of bony fragments
* Non-osteoporotic fracture
* Concomitant neoplasm
C: Inclusion Criteria:

* Confirmed osteoporosis or osteopenia by a referring physician and/or medical history and physical exam OR osteopenia on plain film
* Vertebral compression fracture in vertebrae T4 through L5, of less than 1 year old
* Pain not responsive to standard medical therapy
* Current rating for pain intensity of at least 3 on a scale of 0 to 10

Exclusion Criteria:

* Evidence or suspicion of malignant tumor or spinal canal compromise
* Concomitant hip fracture
* Local or systemic infection
* Uncorrectable bleeding diatheses
* Surgery within the previous 60 days
* Lack of access to telephone
* Inability to communicate in English
* Dementia
* Pregnancy
* Abnormal renal function or anticipated venography
* Conscious sedation is contraindicated for subject
D: Inclusion Criteria:

* VCF on X-ray of the spine (minimal 15% loss of height)
* level of VCF Th5 or lower
* back pain ≤ 6 weeks at time of X-ray
* ≥ 50 years of age
* bone edema on MRI of the fractured vertebral body
* focal tenderness on VCF level
* decreased bone density T-scores ≤ -1

Exclusion Criteria:

* severe cardio-pulmonary condition
* untreatable coagulopathy
* systemic or local infection of the spine (osteomyelitis, spondylodiscitis)
* suspected alternative underlying disease (malignancy)
* radicular and/or cauda compression syndrome
* contra-indication for MRI

Answer: B
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Healthy Kids-Houston: An Integrated Community Program for the Prevention of Obesity Among Minority Children
Brief Summary: The collaborative study is to determine the effectiveness of an after-school community-based program to prevent obesity among minority children.


Options:
A: Inclusion Criteria:

* Healthy kindergarten children

Exclusion Criteria:

* Children with severe chronic disease (restricting physical activity)
B: Inclusion Criteria: Inclusion criteria for children include:

* ability to speak, write, and read in English
* a BMI \> 85th percentile for age and gender
* at least one parent or guardian with a BMI \>25
* assent and their parent or guardian's consent to their participation

Inclusion criteria for parents or guardians include:

* ability to speak, write, and read in English
* a BMI \>25
* a 2nd, 3rd or 4th grade child with a BMI \> 85th percentile for age and gender
* reside with the child; and consent to join the study

Exclusion Criteria: Parents and children will be excluded if either has a:

* history of a heart murmur
* congenital heart disease
* family history of sudden death
* history of psychological problems such as claustrophobia that would prevent participation in group classes
* participation in another clinical trial or intervention
* Asians will be excluded since there is a higher level of risk at a lower BMI than for Blacks, Hispanics, and Whites
C: Inclusion Criteria:

* Live in close proximity of the community centers

Exclusion Criteria:

* Medical or physical conditions that prevent the child from participating in the physical activities
D: Inclusion Criteria:

* Overweight, sedentary children
* Black or white race
* Attending specific schools in Augusta, GA area from which this study is recruiting

Exclusion Criteria:

* Unable to participate in testing or vigorous exercise program
* Diabetes
* Taking medication that would affect study results
* Sibling enrolled in project

Answer: C
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Healthy Kids-Houston: An Integrated Community Program for the Prevention of Obesity Among Minority Children
Brief Summary: The collaborative study is to determine the effectiveness of an after-school community-based program to prevent obesity among minority children.


Options:
A: Inclusion Criteria:

* Live in close proximity of the community centers

Exclusion Criteria:

* Medical or physical conditions that prevent the child from participating in the physical activities
B: Inclusion Criteria:

The participants must meet the following inclusion criteria:

* Female
* Age range 15-20 y
* Overweight to obese (85th -99th percentile for BMI for age; BMI: 25-39.9 kg/m2
* No metabolic, psychological, or neurological diseases/conditions
* Not currently/previously on a weight loss/other special diet
* Frequently eats lunch ( ≥ 5 eating occasions/wk)
* Consistently skips breakfast every week day (i.e., 5 week days/week)
* Right-handed (necessary for the fMRI analyses)

Exclusion Criteria:

The participants will be excluded from participation in the study if they meet the following exclusion criteria:

* Male
* Age \>20 y and \<15 y
* Under Weight (\<5th percentile for BMI for age; BMI: \<18 kg/m2)
* Normal Weight (6th-84th percentile for BMI for age; BMI: 18-24.0 kg/m2)
* Morbidly Obese (BMI: \>40 kg/m2)
* Clinically diagnosed with diabetes (Type I or Type II), having an eating disorder, or having any other metabolic, psychological, or neurological diseases/conditions that would influence the study outcomes.
* Not currently/previously on a weight loss or other special diet (in the past 6 months)
* Skip lunch ( ≥ 2 eating occasions/wk)
* Consume breakfast (≥ 2 eating occasions/wk)
* Left-handed
* Claustrophobic (≥ 2 past bouts of claustrophobia when exposure to small spaces)
* Do not meet the fMRI criteria established by the MU-BIC (regarding metal implants, etc.)
* Pregnant
C: Inclusion Criteria:

* Overweight, sedentary children
* Black or white race
* Attending specific schools in Augusta, GA area from which this study is recruiting

Exclusion Criteria:

* Unable to participate in testing or vigorous exercise program
* Diabetes
* Taking medication that would affect study results
* Sibling enrolled in project
D: Inclusion Criteria:

* all children attending 5th grade at the invited schools in Sogn og Fjordane county (Norway) during the school-year 2014/2015

Exclusion Criteria:

* those children whom for language barriers are unable to perform national tests in Numeracy, Norwegian and English

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Use of Vitamin D to Improve Glucose Metabolism and Reduce Inflammation in Obese Adolescents on a Standard Weight Loss Program
Brief Summary: The investigators' project will study the effects of optimizing the vit D status of obese adolescents on markers of glucose metabolism and inflammation.


Options:
A: Inclusion Criteria:

* greater than or equal to the 85th percentile in BMI
* in 9th through 11th grades at participating schools

Exclusion Criteria:

* BMI greater than or equal to 40
* previously diagnosed type 1 or type 2 diabetes
* blood pressure in the range of stage 2 hypertension
* medications that significantly interfere with weight
B: Inclusion Criteria:

* Must have a parent or primary caregiver who lives in the same house as the adolescent
* Live within 60 miles of the program's office
* Have at least 3 grandparents who are African American
* Access to the internet
* Children between the ages of 11 and 16
* Child must have BMI above 85th percentile and below 99th percentile
* Have no medical condition that would limit participation in moderate intensity exercise including life-threatening illness (e.g., immobile, severely disabled, or bed ridden)
* Available and able to participate in measures and intervention activities over the next year

Exclusion Criteria:

* Adolescents with chronic illness
* Adolescents who require a specialized diet may not be eligible
* Developmental delay
* Partaking currently in another weight loss program
C: Inclusion Criteria:

* Obese children and adolescents aged 10-18

Exclusion Criteria:

Children:

* Having associated learning difficulties
* Who have received medication for associated insulin resistance
* Refusal of parent/legal guardian to give informed consent.
D: Inclusion Criteria:

* Obese adolescent (BMI \> 85th percentile for age)
* 9-19 years of age
* attending the ADOBE clinic at the University of Missouri

Exclusion Criteria:

* use of vit D supplements other than standard multi-vitamin preparation
* (i.e., should not be receiving vit D \> 1000 IU/d) use of medications that interfere with vit D metabolism (e.g., anti-convulsive)
* history of hepatic or renal disorders;
* undergoing ultraviolet radiation as medical therapy;
* pregnancy;
* cigarette smoking;
* current use of commercial tanning bed;

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
Brief Summary: The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.


Options:
A: Inclusion Criteria:

* Women 18 years and older
* seeking medical abortion services
* in general good health
* assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken
* eligible for medical abortion according to clinician and center standards.

Exclusion Criteria:

* will be followed up by beta HCG and not ultrasound
B: Inclusion Criteria:

* Be willing and able to sign consent forms;
* Be eligible for menstrual regulation (MR) services according to clinician's assessment;
* Be willing to undergo a surgical evacuation if necessary;
* Be willing to provide a urine sample prior to administration of the mifepristone
* Have ready and easy access to a telephone and
* Agree to comply with the study procedures and visit schedule

Exclusion Criteria:

* • Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass;

  * Chronic renal failure;
  * Concurrent long-term corticosteroid therapy;
  * History of allergy to mifepristone, misoprostol or other prostaglandin;
  * Hemorrhagic disorders or concurrent anticoagulant therapy;
  * Inherited porphyrias; or
  * Other serious physical or mental health conditions.
C: Inclusion Criteria:

* Reproductive age women seeking abortion services.
* Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
* Participants must be eligible for medical abortion according to clinician and clinic standards.
* In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.
D: Inclusion Criteria:

* Gestational age \< 63 days by LMP, ultrasound or clinical assessment.
* General good health including absence of conditions which contraindicate the use of mifepristone and misoprostol for pregnancy termination.
* Agrees to return for follow-up visit and willing to provide an address and/or telephone number for purposes of follow-up.
* Able to consent to study participation.

Exclusion Criteria:

* Gestational age \> 63 days
* Confirmed or suspected ectopic or molar pregnancy
* Contraindications to medical abortion including IUD in place (must be removed before procedure), chronic adrenal failure, concurrent long-term corticosteroid therapy, history of allergy to mifepristone, misoprostol or prostaglandin, hemorrhagic disorders or concurrent anticoagulant therapy, inherited porphyries.

Answer: C
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Unilateral vs. Bilateral IBV Placement
Brief Summary: Patients with bilateral heterogeneous pulmonary emphysema benefit to differing degrees from unilateral ELVR with complete lobe closure in comparison with incomplete bilateral treatment.


Options:
A: Inclusion Criteria:

* Patients must have a diagnosis of advanced upper lobe predominant (ULP) emphysema or advanced disease in the superior lower lobes as defined by FEV1/FVC \<70 % predicted, FEV1 of \< 50% predicted, TLC \> 100% of predicted, and RV \> 135% predicted.
* Patients must have persistent symptoms despite medical therapy and either not be candidates for Lung Volume Reduction Surgery (LVRS) or have elected not to undergo LVRS.
* Patients must be \> 40 years of age, have symptoms despite medical therapy, and have none of the pre-specified co-morbid conditions that could influence study outcomes or their ability to tolerate bronchoscopy.
B: Inclusion Criteria:

* age \> 40 inhomogeneous emphysema FEV1 between 20-40% DLCO between 20-40% 6MWT \> 150 m

Exclusion Criteria:

* pregnant homogeneous disease FEV1 \< 20%
C: Inclusion Criteria:

* Between 40 and 74 years of age
* Predominantly upper lobe emphysema and severe dyspnea
* Satisfies the criteria of the ATS/ERS Guidelines for Management of Stable COPD
* Physical ability to participate in the study by performing a 6-minute walk distance of \> 140m
* No cigarette smoking for 4 months and willing to abstain throughout the study
* Severe airflow obstruction defined by FEV1 45% of predicted
* Severe hyperinflation defined by: TLC \> 100% of predicted and RV \> 150% of predicted

Exclusion Criteria:

* Between 70 and 74 years of age and an FEV1 or DLCO \< 20% of predicted
* Severe gas exchange abnormalities
* Major medical disease that will limit evaluation, participation or follow-up
* Active asthma component to their disease
* Giant bulla (\> 1/3 volume of lung)
* Severe pulmonary hypertension
* Requirement for \> 6L02 to keep saturation \> 90% with exercise
* Evidence of systemic disease or neoplasia expected to compromise survival during the 6-month study period
D: Inclusion Criteria:

* Heterogeneous emphysema
* Able to obtain a Chartis value during Assessment

Exclusion Criteria:

* Any co-existing major medical problems that would not make it possible for the subject to tolerate a bronchoscopic procedure.

Answer: B
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
Brief Summary: The purpose of this study is to test a mother-to-mother intervention during pregnancy and after delivery with mothers in South Africa, most of whom are at risk delivering babies with fetal alcohol syndrome, babies that are underweight, or babies that are infected with HIV from an HIV-positive mother. The investigators hypothesize that the intervention will reduce the chance of these three health outcomes occurring in the babies and improve the health of the mother.


Options:
A: Inclusion Criteria:

* Resident of Grenada
* One or more vascular risk factors:

  * Borderline to elevated blood pressure (defined as systolic blood pressure ≥120 mm Hg to SBP \< 160 or diastolic blood pressure ≥ 80 and \< 90 mm Hg)
  * Waist circumference of \>40 inches for men and \>35 inches for women
  * Smoking (active self-reported smoking, of any type of tobacco, at least daily)
  * Physical inactivity (reporting less than 120 min/week of activity)
  * Fasting glucose level \> 100 mg/dl
  * Total Cholesterol \>250 mg/dl, LDL \> 130 mg/dl
  * Fruit/vegetable intake less than 2 servings daily

Exclusion Criteria:

* Unable/unwilling to provide consent
* Age of under 18 or more than 70 years old (inclusive) as of December 2012
* Inability of self-monitoring
* Pregnant women
* Morbidly ill with expectation of death within a year
B: Inclusion Criteria:

* Parents or primary caregivers (age 18 or above) of children ages 3-7 enrolled in kindergarten
* Resident in one of five study sites

Exclusion Criteria:

* Severe cognitive disability of caregiver affecting ability to provide informed consent
C: Inclusion Criteria:

* HIV-positive
* Eligible for public sector ARV treatment (CD4\<200 and/or WHO stage 4)
* Commenced ARV treatment in past 4 weeks
* Patient resident in town/village where ART clinic located

Exclusion Criteria:

* HIV-negative
* Not eligible for public sector ARV treatment
* Had not commenced ARV treatment
* Commenced ARV treatment longer than one month ago
* Patient not resident in town/village where ART clinic
D: Inclusion Criteria:

* Pregnant woman and their children
* Age 18 or older
* Informed consent

Exclusion Criteria:

* Psychosis, neurological damage, inability to communicate with interviewer
* Inability to give consent

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
Brief Summary: The purpose of this study is to test a mother-to-mother intervention during pregnancy and after delivery with mothers in South Africa, most of whom are at risk delivering babies with fetal alcohol syndrome, babies that are underweight, or babies that are infected with HIV from an HIV-positive mother. The investigators hypothesize that the intervention will reduce the chance of these three health outcomes occurring in the babies and improve the health of the mother.


Options:
A: Inclusion Criteria:

* Infant Born at Katz Women's Hospital at Long Island Jewish (LIJ) Medical Center
* Mother Age 18 years or older
* Mother who has delivered a single live born normal infant, vaginally or by cesarean section
* Mother Primary Language Spoken is English

Exclusion Criteria:

* Loss of Pregnancy
* Fetal demise
* No health insurance
* Infant in neonatal intensive care unit
B: Inclusion Criteria:

* Pregnant woman and their children
* Age 18 or older
* Informed consent

Exclusion Criteria:

* Psychosis, neurological damage, inability to communicate with interviewer
* Inability to give consent
C: Inclusion Criteria:

* at least 18 years of age
* delivered vaginally a healthy, full-term (at least 37 weeks gestation) baby
* received prenatal care services at the VCUMCV OB clinic
* speak English
* provide informed consent for study participation.

Exclusion Criteria:

* cognitive impairment, psychiatric instability, or language barriers that limit their ability to provide informed consent
* surgically sterilized
* have complicated deliveries that require extended hospital stays
* need early follow-up to monitor their conditions
* any problems with infants such as preterm birth, admission to the Neonatal Intensive Care Unit (NICU), congenital malformations or respiratory problems that would require frequent clinic visits or prolonged hospital admissions for the infants.
D: Inclusion Criteria:

* pregnant women (gestational week 35-36)

Exclusion Criteria:

* women with known physical, psychological and/or social illness/problem that result in hospitalization more than 50 hours after delivery
* women with known pregnancy related illness that result in hospitalization more than 50 hours after delivery
* Women not understanding or speaking Danish
* women expecting multiple babies
* women having decided not to breastfeed
* women expecting to deliver at another hospital than the one she has been visiting during pregnancy

Answer: B
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
Brief Summary: The purpose of this study is to test a mother-to-mother intervention during pregnancy and after delivery with mothers in South Africa, most of whom are at risk delivering babies with fetal alcohol syndrome, babies that are underweight, or babies that are infected with HIV from an HIV-positive mother. The investigators hypothesize that the intervention will reduce the chance of these three health outcomes occurring in the babies and improve the health of the mother.


Options:
A: Inclusion Criteria:

* Pregnant woman and their children
* Age 18 or older
* Informed consent

Exclusion Criteria:

* Psychosis, neurological damage, inability to communicate with interviewer
* Inability to give consent
B: Inclusion Criteria:

* pregnant women (any age)
* newborns

Exclusion Criteria:

* children (outside newborn period)
C: Inclusion Criteria:

* pregnant woman in program area (in 20 townships) from August 2000 to March 2003

Exclusion Criteria:

* outsiders of program area
D: Inclusion Criteria:

* participants consenting for the home-based care model area
* participants who consent for household adequacy survey
* participants who consent from clinic care model area

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
Brief Summary: The purpose of this study is to test a mother-to-mother intervention during pregnancy and after delivery with mothers in South Africa, most of whom are at risk delivering babies with fetal alcohol syndrome, babies that are underweight, or babies that are infected with HIV from an HIV-positive mother. The investigators hypothesize that the intervention will reduce the chance of these three health outcomes occurring in the babies and improve the health of the mother.


Options:
A: Inclusion Criteria:

* Pregnant woman and their children
* Age 18 or older
* Informed consent

Exclusion Criteria:

* Psychosis, neurological damage, inability to communicate with interviewer
* Inability to give consent
B: Inclusion Criteria:

* Patient in the Maternity Unit at Mount Sinai Hospital
* Infant has a birth weight greater than or equal to 2,500 grams
* Infant has a 5-minute Apgar score greater than or equal to 7
* Self-identifies as White or minority other than Black or Hispanic; Black and Hispanic women will be referred to a parallel study with the same protocol at Mount Sinai Hospital
* Speaks English
* Has a working telephone
C: Inclusion Criteria:

* Families in the Oahu community who delivered newborns between November 1994 and November 1995
* If enrolled in the control group, must not have been previously enrolled in Hawaii's Healthy Start Program

Exclusion Criteria:

* Insufficient understanding of English
D: Inclusion Criteria:

* Patient in the Maternity Unit at Mount Sinai Hospital
* Infant has a birth weight greater than or equal to 2,500 grams
* Infant has a 5-minute Apgar score greater than or equal to 7
* Self-identifies as Black/African American or Hispanic/Latina; White or minority other than Black/African American or Hispanic/Latina will be referred to a parallel study with the same protocol at Mount Sinai Hospital
* Speaks English or Spanish
* Has a working telephone

Answer: A